Julia Liu, MD
Gastroenterology · Atlanta, GANPI 1932165222
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), grants and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Braintree Laboratories, Inc. at 30.6% of the total. 2025 is the largest year on record at $68,945, more than ten times the $396 reported in 2019. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $1634.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braintree Laboratories, Inc.$50K
- Janssen Scientific Affairs, LLC$31K
- Takeda Pharmaceuticals U.S.A., Inc.$26K
- Pfizer$17K
- E.r. Squibb & Sons, L.L.C.$16K
- Janssen Research & Development, LLC$12K
- plus $12K from 14 others
Across 26 payments — averaging $10,739 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$104K
- Bausch Health US, LLC$62K
- Eli Lilly$51K
- Pfizer$16K
- Boehringer Ingelheim International GmbH$16K
- Mauna Kea Technologies, Inc.$12K
- plus $18K from 3 others
What the payments were for
- Consulting fees$91,11856%
- Speaking & faculty fees$15,0509%
- Grants$50,00031%
- Travel & lodging$3,6972%
- Food & beverage$3,5292%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braintree Laboratories, Inc. | 1 | $50,000 |
| Janssen Scientific Affairs, LLC | 5 | $31,347 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $25,625 |
| Pfizer | 8 | $16,544 |
| E.r. Squibb & Sons, L.L.C. | 5 | $15,710 |
| Janssen Research & Development, LLC | 5 | $11,760 |
| Eli Lilly | 14 | $5,550 |
| Lilly USA, LLC | 1 | $1,900 |
| AbbVie | 15 | $1,432 |
| Johnson & Johnson | 10 | $1,313 |
| Mauna Kea Technologies, Inc. | 3 | $1,064 |
| Boston Scientific | 3 | $239 |
| Baxter Healthcare | 2 | $205 |
| Bristol Myers Squibb | 3 | $196 |
| THD America, Inc. | 1 | $168 |
| Genentech USA, Inc. | 1 | $133 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Genentech, Inc. | 1 | $92 |
| Cook Medical LLC | 1 | $81 |
| Madrigal Pharmaceuticals | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$163,483 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 12 | $58,871 |
| Sucralfate | 26 | $3,463 |
| Lactulose | 17 | $2,082 |
| Esomeprazole Magnesium | 41 | $1,297 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 68 | $1,025 |
| Dicyclomine Hcl | 13 | $429 |
| Omeprazole | 26 | $388 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $283 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Atlanta
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Marc SonenshineAtlanta$201K
- Huiming HonAtlanta$159K
- Norman GitlinAtlanta$151K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.